- 3.4Impact Factor
- 9.9CiteScore
- 20 daysTime to First Decision
Vaccines, Volume 10, Issue 12
December 2022 - 205 articles
Cover Story: Although heterologous prime–boost vaccinations potentially augment the immune response against SARS-CoV-2, data among liver transplant (LT) recipients are limited. We assessed humoral and cellular immune responses after primary vaccination and booster doses in LT recipients who received homologous (ChAdOx1/BNT162b2) or heterologous (ChAdOx1/ChAdOx1) vaccinations. We observed a decreased immune response three months post primary vaccination. The booster significantly improved immune responses. Most LT recipients exhibited strong immunity against the wild-type strains; however, the neutralising activity against Omicron variants was substantially lower in both groups despite the booster vaccination. Additional strategies may be required to protect against the Omicron variant in LT recipients to mitigate the ongoing SARS-CoV-2 pandemic. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Vaccines - ISSN 2076-393XCreative Common CC BY license